North America Biopharmaceutical Contract Manufacturing Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Product (Biologics, Biosimilars); Service (Development Process, Final Dosage Operation, Analytical and Quality Control, Final Packaging), and Geography

Code: TIPRE00010242 | Pages: 133 | Industry: Pharmaceuticals | Date: Apr 2020
Covid

The North America biopharmaceutical contract manufacturing market is expected to reach US$ 11,754.24 Mn in 2027 from US$ 6,202.70 Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2019-2027.

 

The growth of the market is driven by factors such as the increasing outsourcing by pharmaceutical companies and increasing demand of biologics in the North America region. However, increasing competition in the industry is likely to restrain the market growth to a certain extent.

 

Manufacturing of Biopharmaceutical medicines through contract manufacturer from DNA to finished final product. Contract manufacturing is the type of outsourcing where a company enters into an agreement or legal settlement with another manufacturing firm for products, parts, or components, which the former will then use in its production process to complete its product. This involves manufacturing of biopharmaceutical molecules, proteins, nucleic acids, blood components, and vaccines developed from a biological source. These companies are specialized in the production of molecules and offer different types of services such as Development Process, Analytical and Quality Control among others.

 

The contract manufacturing market for biologics is growing at an unprecedented rate owing to increasing biologics pipeline, manufacturing complexity, and companies shifting their focus towards core activities. Presently, many pharmaceutical and biotechnology companies outsource varied services from early-stage drug development to commercial-scale manufacturing. The outsourcing is required to expedite research and development, speed up market entry, give access to novel technologies, regulatory expertise, and reduces risks at a competitive cost. Complexities in biologics development and production and increasingly stringent quality standards have driven drug manufactures to prefer contract manufacturer services. A significant boom has been witnessed in the contract manufacturing of biologics. This can be attributed to difficulties in the production of a large-scale biologics in house. As the pharmaceutical industry is shifting from large scale production to more niche and targeted therapies (personalized medicine), the demand of flexible operational capabilities, production scales, and multiple-product operations are offering significant advantages to CMOs. Many companies are opting CMOs services to speed up the development process and lower production costs. For instance, in 2019, Dyadic International, Inc. agreed with Luina Bio Pty Ltd for the development and commercialization of its specific targeted antigen and biological products. Thus, increasing demand of biologics is expected to drive the growth of the biopharmaceutical contract manufacturing market in North America during the forecast period.

 

Highly efficient manufacturing and research activities in North America are key factors driving the growth of contract manufacturing market in the region. Recent growth in the biopharmaceutical industry indicates a positive future outlook for the market. Moreover, the growing market and its pipelines are further opening new avenues for the contract manufacturers in the North America. The anticipated success of the biopharmaceutical market is dependent on new biologics currently under development and biosimilars which has shown rapid growth in recent years. Due to the rising number of start-ups engaged in novel biologics R&D, the CMOs have major opportunities in this area. Contract manufacturing is expected to contribute to the overall industry’s growth, and mostly benefit early-stage drug innovators owing to less operational cost. Moreover, in 2018, approval of monoclonal antibodies accounted for nearly 20 per cent of all drugs approved by the FDA. Compared to previous years' approvals, this number had reached 27 antibody-based drugs out of a total of 127 new drugs over the past three years. The increasing research activities in addition to technological advancements are likely to offer significant opportunity for the growth of the market.

 

 

Mexico Biopharmaceutical contract manufacturing market Revenue and Forecasts to 2027 (US$ Bn)

Mexico Biopharmaceutical contract manufacturing market Revenue and Forecasts to 2027 (US$ Bn)

Get more information on this report :


 

NORTH AMERICA BIOPHARMACEUTICAL CONTRACT MANUFACTURING – MARKET SEGMENTATION

North America Biopharmaceutical Contract Manufacturing Market - By Product

  • Biologics
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Others
  • Biosimilars

 

North America Biopharmaceutical Contract Manufacturing Market - By Service

  • Development Process
  • Final Dosage Operation
  • Analytical and Quality Control
  • Final Packaging

North America Biopharmaceutical Contract Manufacturing Market - By Country

  • US
  • Canada
  • Mexico

North America Biopharmaceutical Contract Manufacturing Market - Companies Mentioned

  • Lonza Group AG
  • Boehringer Ingelheim International GmbH
  • Inno Biologics Ventures Sdn Bhd
  • Thermo Fisher Scientific
  • AbbVie Inc.
  • WuXi Biologics
  • General Electric
  • Samsung Biologics
  • Merck KGaA
  • Ajinomoto Co., Inc

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        North America Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        North America Biopharmaceutical Contract Manufacturing Market – By Country

2.           North America Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Biopharmaceutical Contract Manufacturing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        4.2.1 Biopharmaceutical Contract Manufacturing Market - North America PEST Analysis

4.3         Expert Opinion

5.           North America Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Outsourcing by Pharmaceutical Companies

5.1.1        Increasing Demand of Biologics

5.2         Key Restraints

5.2.1        Increasing Competition in the Industry

5.3         Key Market Opportunities

5.3.1        Robust advancements in research and development activities

5.4         Future Trend

5.4.1        Consolidation in Pharmaceutical CMO Industry

5.5         Impact Analysis

6.           Biopharmaceutical Contract Manufacturing Market – North America Analysis

6.1         North America Biopharmaceutical Contract Manufacturing Market Revenue Forecasts and Analysis

7.           North America Biopharmaceutical Contract Manufacturing Market Analysis And Forecasts To 2027 – By Product

7.1         Overview

7.2         North America Biopharmaceutical Contract Manufacturing Market, By Product 2019 & 2027 (%)

7.2.1        North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3         Biologics

7.3.1        Overview

7.3.2        North America Biologics Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3        Monoclonal Antibodies

7.3.3.1          Overview

7.3.3.2          North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4        Recombinant Proteins

7.3.4.1          Overview

7.3.4.2          North America Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.5        Vaccines

7.3.5.1          Overview

7.3.5.2          North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.6        Others

7.3.6.1          Overview

7.3.6.2          North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.4         Biosimilars

7.4.1        Overview

7.4.2        North America Biosimilars Market Revenue and Forecast to 2027 (US$ Mn)

8.           North America Biopharmaceutical Contract Manufacturing Market Analysis – By Service

8.1         Overview

8.2         North America Biopharmaceutical Contract Manufacturing Market, By Service 2019-2027 (%)

8.2.1        North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecasts to 2027, By Service (US$ Mn)

8.3         Development Process

8.3.1        Overview

8.4         North America Development Process Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Final Dosage Operation

8.5.1        Overview

8.6         North America Final Dosage Operation Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Analytical and Quality Control

8.7.1        Overview

8.7.2        North America Analytical and Quality Control Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Final Packaging

8.8.1        Overview

8.8.2        North America Final Packaging Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Biopharmaceutical Contract Manufacturing Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.3.1          North America: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.4        North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027  (USD Million)

9.1.5        North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

9.1.6        US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.6.2.1          US: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.6.3          US: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.1.7        Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.7.2.1          Canada: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.7.3          Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

9.1.8        Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2018–2027 (USD Million)

9.1.8.2.1          Mexico: Biologics Market, by Type, 2018–2027 (USD Million)

9.1.8.3          Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2018–2027 (USD Million)

10.        Impact of COVID-19 Pandemic on North America Biopharmaceutical Contract Manufacturing Market

10.1      North America: Impact assessment of COVID-19 Pandemic

11.        North America Biopharmaceutical Contract Manufacturing Market Industry Landscape

11.1      Overview

11.2      Growth Strategies Done by the Companies in the Market, (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      THERMO FISHER SCIENTIFIC INC.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      General Electric Company

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Lonza

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Samsung Biologics.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      AbbVie Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2.             North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecasts To 2027, By Service (US$ Mn)

Table 1.             North America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 4.             US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 5.             US Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 7.             Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico Biologics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2027  (USD Million)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

 


LIST OF FIGURES

Figure 1.           Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           North America Biopharmaceutical Contract Manufacturing Market Overview

Figure 3.           Biologics Segment Held Largest Share Of Product In Biopharmaceutical Contract Manufacturing Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Biopharmaceutical Contract Manufacturing Market- Leading Country Markets (US$ Mn)

Figure 6.           North America Biopharmaceutical Contract Manufacturing Market, Industry Landscape

Figure 7.           Biopharmaceutical Contract Manufacturing Market - North America PEST Analysis

Figure 8.           Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Biopharmaceutical Contract Manufacturing Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        North America Biopharmaceutical Contract Manufacturing Market, By Product 2019 & 2027 (%)

Figure 11.        North America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        North America Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        North America Biosimilars Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        North America Biopharmaceutical Contract Manufacturing Market, by Service 2019 & 2027 (%)

Figure 18.        North America Development Process Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        North America Final Dosage Operation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        North America Analytical and Quality Control Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        North America Final Packaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        North America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)

Figure 25.        US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Projection of the Use of Pharmaceutical Products in Mexico (Million Dollars)

Figure 28.        Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Impact Of Covid-19 Pandemic In North American Country Markets

Figure 30.        Growth Strategies Done by the Companies in the Market, (%)

 

 

The List of Companies - North America Biopharmaceutical Contract Manufacturing Market

  1. Lonza Group AG
  2. Boehringer Ingelheim International GmbH
  3. Inno Biologics Ventures Sdn Bhd
  4. Thermo Fisher Scientific
  5. AbbVie Inc.
  6. WuXi Biologics
  7. General Electric
  8. Samsung Biologics
  9. Merck KGaA
  10. Ajinomoto Co., Inc

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America biopharmaceutical contract manufacturing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America biopharmaceutical contract manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Related Tags North America Biopharmaceutical Contract Manufacturing Market North America Biopharmaceutical Contract Manufacturing Market Research North America Biopharmaceutical Contract Manufacturing Market Insight North America Biopharmaceutical Contract Manufacturing Market Trends North America Biopharmaceutical Contract Manufacturing Market Forecast North America Biopharmaceutical Contract Manufacturing Market Share North America Biopharmaceutical Contract Manufacturing Market 2027 North America Biopharmaceutical Contract Manufacturing Market Growth North America Biopharmaceutical Contract Manufacturing Industry Sector North America Biopharmaceutical Contract Manufacturing PDF Report North America Biopharmaceutical Contract Manufacturing Analysis North America Biopharmaceutical Contract Manufacturing Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000